Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/6/2026

1. LULU
2. ZS
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC
(NASDAQ: ALZN) Delayed: 1.66 -0.04 (2.35%)
Previous Close $1.70    52 Week High $ 
Open $1.70    52 Week Low $ 
Day High $1.73    P/E N/A 
Day Low $1.65    EPS $ 
Volume 63,178